Hi, I’m Irwin Goldstein. I’m a Sexual Medicine Physician. I am Director of the Sexual Medicine Program here in Alvarado Hospital in San Diego, California and I am an EmpoweHer advisory board member.
If god is good and that means the FDA, and if the drug company involved has the appropriate application, hopefully, some time early next year probably end of first quarter the Food and Drug administration will make some historic announcement that a medication will have been reviewed for a safety information and its efficacy information and deemed acceptable for use in women who have a kind of sexual dysfunction called, HSDD, which means Hypoactive Sexual Desire Disorder. Of all the sexual dysfunctions in women low interest, can’t arouse, can’t lubricate, dry vagina, poor orgasm, no pleasure from orgasm, sexual pain—the most common is low interest. So HSDD will have I guess if this happens the first ever FD approved product for women who have a sexual health concern.
Essentially its role is to change the chemical balance. In essence this is the balance and it can tip towards inhibition which these women have or can tip towards excitation which some women have too much excitations. Some women their genitals are aroused all the time, so they are tipped towards excitation. Some women are tipped towards inhibition and the idea of the medication is to flip the inhibition back to at least a better chance for the woman to excite during the appropriate sexual times.
Transcription by:
Scribe4you Transcription Services